Showing results (11-20 of 124) with videos related to
Sort By:
Pageof 13
Current Opinion in Investigational Drugs (London, England : 2000)|February 24, 2010
Apelin and ACE2 in cardiovascular diseaseAnastasia Z Kalea, Daniel BatlleAdvances in Chronic Kidney Disease|August 25, 2018
Hypokalemic Distal Renal Tubular AcidosisPatricia G Vallés, Daniel BatlleThescientificworldjournal|October 29, 2008
Acute renal failure from adulteration of milk with melamineVincent L Yang, Daniel BatlleFrontiers in Nephrology|June 10, 2026
Long-term outcomes of tacrolimus conversion to sirolimus in kidney transplant recipients: an eight-year follow-upIbrahim Tawhari, Sook Park, Fatmah Yamani, et al.Advances in Chronic Kidney Disease|April 12, 2005
Predicting the development of diabetic nephropathy and its progressionJosette William, Donn Hogan, Daniel BatlleClinical Science (London, England : 1979)|November 2, 2020
ACE2, the kidney and the emergence of COVID-19 two decades after ACE2 discoveryEnrique Lores, Jan Wysocki, Daniel BatlleKidney360|May 25, 2023
FSGS and COVID-19 in Non-African American PatientsElba Medina, Carlos Rueda, Daniel BatlleHypertension (Dallas, Tex. : 1979)|December 3, 2024
ACE2, From the Kidney to SARS-CoV-2: Donald Seldin Award Lecture 2023Daniel Batlle, Luise Hassler, Jan WysockiClinical Journal of the American Society of Nephrology : CJASN|July 5, 2024
Primary Distal Renal Tubular Acidosis: Toward an Optimal Correction of Metabolic AcidosisElba Medina, Gema Ariceta, Daniel BatlleSeminars in Nephrology|November 14, 2002
Comorbidity and cardiovascular risk factors in patients with chronic kidney diseaseJames Paparello, Abhijit Kshirsagar, Daniel BatllePageof 13